05 / March / 2026 “Without a control group, we cannot say that polylaminin works,” says coauthor of study on the substance For neurosurgeon and UFRJ professor Paulo Louzada, flaws in the methodology prevent conclusions about the effectiveness of polylaminin Por Moura Leite Netto
27 / January / 2026 “You cannot do good science in your spare time,” says author of study highlighted at European cardiology conference Cardiologist Pedro Lemos explains the intricacies of a large multicenter study involving over 3,000 patients, the results of which could be used by Brazil’s public health system (SUS). Por Moura Leite Netto
12 / June / 2024 COVID-19: High levels of immunity hinder clinical trials Clinical trials conducted in 2021 and 2022 were unable to find a dosage of the SARS-CoV-2 virus capable of infecting volunteers in challenge studies Por Editorial staff
01 / March / 2024 Gene therapy for hypertrophic cardiomyopathy Preclinical trials demonstrate the potential of a single intervention to silence pathogenic alleles and prevent development of the disease Por Marina Gomes Ricardo Muniz
